Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.

The apparent octanol-water partition coefficients (Po/w) and aqueous solubilities for four 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors [pravastatin, lovastatin (mevinolin), mevastatin (compactin), and simvastatin (synvinolin)] were compared. Pravastatin is highly hydrophilic compared with lovastatin, mevastatin, or simvastatin. Pravastatin is clinically used as the active hydroxy acid, while the other three compounds are administered as prodrug lactones which, over a period of time, convert in vivo to their respective active hydroxy acid forms. The order of the Po/w values of the hydroxy acid forms was pravastatin much less than mevastatin less than lovastatin less than simvastatin at each pH evaluated, with approximate ratios of 1:25:75:200, respectively. The relative order and the ratios of partition coefficients for the lactone forms were similar to those for the hydroxy acid forms. In addition, lovastatin, mevastatin, and simvastatin are virtually insoluble in water, with solubility values ranging from 0.0013 to 0.0015 mg/mL at 23 degrees C. In comparison, pravastatin is hydrophilic, as demonstrated by the greater than 100-fold greater solubility of its lactone form (0.18 mg/mL). The greater hydrophilicity of pravastatin may explain its reported lower permeation into nonhepatic cells and the selectivity with respect to inhibition of cholesterol synthesis.

[1]  H. Mabuchi,et al.  Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine. , 1983, The New England journal of medicine.

[2]  D R Abernethy,et al.  Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol. , 1984, Cardiology.

[3]  J. D. Karkas,et al.  Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. , 1989, Biochemical and biophysical research communications.

[4]  J. Hoeg,et al.  3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. , 1987, JAMA.

[5]  M. L. Robinson,et al.  An investigation of the comparative liposolubilities of β‐adrenoceptor blocking agents , 1981, The Journal of pharmacy and pharmacology.

[6]  H. Pan,et al.  Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin , 1990, Journal of clinical pharmacology.

[7]  I. Chen,et al.  The physiological disposition of lovastatin. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[8]  S. Grundy HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. , 1988, The New England journal of medicine.

[9]  D. Greenblatt,et al.  Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration. , 1985, American heart journal.

[10]  R. Tanaka,et al.  Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens. , 1989, Journal of lipid research.

[11]  A. Leo,et al.  Partition coefficients and their uses , 1971 .

[12]  Y Hata,et al.  The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects. , 1987, JAMA.

[13]  H. Canzler,et al.  COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIA , 1988, The Lancet.

[14]  S. Grundy,et al.  HMG-CoA reductase inhibitors for hypercholesterolemia. , 1988, The New England journal of medicine.

[15]  M. Bonati,et al.  Correlation between n‐octanol/water partition coefficient and liquid chromatographic retention for caffeine and its metabolites, and some structure‐pharmacokinetic considerations , 1987, The Journal of pharmacy and pharmacology.

[16]  Y. Tsujita,et al.  CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. , 1986, Biochimica et biophysica acta.

[17]  R. Heel,et al.  Lovastatin , 2012, Drugs.